Conmed Corporation earnings releases CNMD

Conmed Corporation last reported quarterly results on Oct 28, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $335.6 million (-0.7% year over year) and diluted EPS of $0.66. It usually reports 28–29 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 27, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 28–29 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Oct 28, 2026
28 days after quarter end
Q3 FY2026
ended Sep 30, 2026
336
-0.7%
20
+592.4%
0.66
+633.3%
Jul 29, 2026
29 days after quarter end
Q2 FY2026
ended Jun 30, 2026
343
+0.3%
23
+7.7%
0.77
+11.6%
Apr 29, 2026
29 days after quarter end
Q1 FY2026
ended Mar 31, 2026
—
—
—
Jan 28, 2026
28 days after quarter end
Q4 FY2025
ended Dec 31, 2025
373
+7.9%
17
-50.4%
0.54
-50.4%
Nov 5, 2025
36 days after quarter end
Q3 FY2025
ended Sep 30, 2025
338
+6.7%
3
-94.2%
0.09
-94.3%
Jul 30, 2025
30 days after quarter end
Q2 FY2025
ended Jun 30, 2025
342
+3.1%
21
-28.5%
0.69
-28.1%
Apr 30, 2025
30 days after quarter end
Q1 FY2025
ended Mar 31, 2025
321
+2.9%
6
-69.4%
0.19
-69.8%
Feb 5, 2025
36 days after quarter end
Q4 FY2024
ended Dec 31, 2024
346
+5.8%
34
+2.1%
1.08
+3.2%

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
CNMD (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Largo, FL
SEC filer status
Large accelerated filer
SEC CIK
816956

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.